NB-02

N/A

Report date: 2025/08/13 20:02:02

Base Information

Drug NameNB-02
Drug Alias NameNB-02DA-9803
ClassificationNatural product/Extract
Mechanisms of ActionAnti-TAUAcetylcholinesterase inhibitorsAmyloid beta-protein precursor inhibitors
TargetsMicrotubule-associated protein tauAcetylcholinesteraseAmyloid beta-protein precursor
Therapy Area/IndicationsAlzheimer DiseaseLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDong-A ST Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNOBO Medicine Inc
Inactive CompaniesNeurobo Pharmaceuticals Inc
Active IndicationsLymphoma, Non-Hodgkin
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A